Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-087067
Filing Date
2025-09-03
Accepted
2025-09-03 16:33:50
Documents
1
Period of Report
2025-08-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2525145-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2525145-5_4seq1.xml 4 12476
  Complete submission text file 0001104659-25-087067.txt   13921
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Issuer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIQUIDIA CORPORATION 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address
Moomaw Scott (Reporting) CIK: 0001832592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39724 | Film No.: 251290299